Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.

Wyatt NJ. et al, (2024), BMJ open, 14

Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease

Zhang H. et al, (2024), Nature Communications, 15

Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumab.

Dallari S. et al, (2024), Scientific reports, 14

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.

Wong S-Y. et al, (2023), Inflammatory bowel diseases, 29, 1693 - 1705

Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.

Wellens J. et al, (2023), Inflammatory bowel diseases

Prenatal cannabis exposure alters offspring DNA methylation at genes involved in neurodevelopment, across the life course

Osborne A. et al, (2023)

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774

Editorial: in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation-authors' reply.

Chen J. et al, (2023), Alimentary pharmacology & therapeutics, 57, 1034 - 1035

Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases-moving towards causal associations. Authors' reply.

Chen J. et al, (2023), Alimentary pharmacology & therapeutics, 57, 1048 - 1049

Defining gene-lifestyle interactions in inflammatory bowel disease: progress towards understanding disease pathogenesis.

Zhao J. et al, (2023), Gut

Defining Interactions Between the Genome, Epigenome, and the Environment in Inflammatory Bowel Disease: Progress and Prospects.

Noble AJ. et al, (2023), Gastroenterology

Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.

Chen J. et al, (2023), Journal of Crohn's & colitis, 17, 535 - 552

Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome.

Kalla R. et al, (2023), Journal of Crohn's & colitis, 17, 170 - 184

Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.

Adams A. et al, (2023), Gut, 72, 433 - 442

Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease.

Joustra V. et al, (2023), Journal of Crohn's & colitis, 17, 185 - 198

Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research

Alexander JL. et al, (2023), Gut

The Contribution of Genetic Risk and Lifestyle Factors in the Development of Adult-Onset Inflammatory Bowel Disease: A Prospective Cohort Study.

Sun Y. et al, (2023), Am J Gastroenterol

SerumN-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease

Shubhakar A. et al, (2023), Journal of Crohn's and Colitis

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.

Louis E. et al, (2023), Lancet Gastroenterol Hepatol

Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study.

Chen J. et al, (2023), Alimentary pharmacology & therapeutics

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?